GlassScriptPhysician profile
Travis Edward Clegg
NPI 1740494418
$4,833.77
in general payments reported to CMS, 2019-2025
14 companies · $2,104 in 2025
The $2,104 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $215 · 2021: $814 · 2022: $150 · 2023: $93.76 · 2024: $1,166 · 2025: $2,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,750 · Travel and Lodging: $1,203 · Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,750.00 |
| Travel and Lodging | $1,203.25 |
| Food and Beverage | $410.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $3,383.33 | 2019-2025 | Gmk Sphere, Moto Uni |
| Globus Medical, INC. | $630.01 | 2021 | |
| US Implant Solutions, LLC | $311.65 | 2019-2023 | |
| Pacira Therapeutics, INC. | $190.45 | 2020-2021 | |
| Integrity Orthopaedics, INC. | $74.72 | 2024 | Integrity Orthopaedics |
| Eagle Pharmaceuticals, INC. | $47.89 | 2023 | |
| Alpha Orthopedic Systems | $44.58 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $27.68 | 2025 | |
| Amgen INC. | $23.81 | 2020 | |
| Heron Therapeutics, INC. | $23.40 | 2025 | Zynrelef |
| Acacia Pharma INC | $21.97 | 2021 | |
| Depuy Synthes Sales INC. | $19.64 | 2024 | Orthovisc |
| Orthofix Medical, INC. | $18.64 | 2025 | Physio-Stim |
| Allergan, INC. | $16.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Clegg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.